Let Your Voice Be Heard at Digital RESI JPM

18 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

As Digital RESI November closes today, the team at Life Science Nation is looking ahead to Digital RESI JPM, January 11-13, 2022. In addition to RESI’s powerful partnering system, the virtual panels are a highlight for investors and fundraising entrepreneurs alike. RESI panels feature industry innovators and subject matter experts to discuss navigating the early-stage ecosystem within life science and healthcare, tackling topics relevant to fundraising and company-building.

Is there a topic you’d like to see at Digital RESI JPM? Would you recommend a particular industry expert or prolific investor to speak to fundraising in this space? We want to hear from you and highlight the issues and stories that are most meaningful to the RESI community. Send your suggestions to RESI@lifesciencenation.com and sign up for Digital RESI JPM by Friday, November 28 to save $300!

Digital RESI JPM Pitch Applications Open

18 Nov

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


Today is the last day of the Digital RESI November Innovator’s Pitch Challenge. If you missed your opportunity to pitch to relevant investors seeking opportunities in your space, Digital RESI JPM, January 11-13, 2022 is right around the corner! Join us at the biggest virtual fundraising event of the year and submit your application the the Digital RESI JPM Innovator’s Pitch Challenge.

What is it?

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $800 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

How Does it Work?

Pitching companies will have a dedicated webpage on the Live Agenda, which greatly increases visibility to investors. Prior to the live pitch session, the investor panel will review submitted pitch materials and prepare questions.

Each company has approximately 10 minutes set aside for their participation. Each session is judged by a panel of investors who have expressed interest in the sector(s) highlighted in the session. During the session, the pitching company delivers a brief (~1 minute) elevator pitch, and saves the rest of their time for investors’ questions, feedback and commentary. The session is open to all registered RESI attendees.


Who Should Apply?

Early-stage life science companies actively raising seed capital (25K-2MM), Series A (2MM-10MM), or Series B (10MM-50MM) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to submit an application, along with a pitch deck and an executive summary. Once selected to pitch, companies can submit their video and supplemental materials for investors to review prior to the live session.

Apply for IPC with Icon

Digital RESI November at a Glance

18 Nov

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Digital RESI November is not over yet but has so far been one of our most successful virtual events. With over 600 attendees from 30 countries across 5 continents, RESI continues to demonstrate how truly global Life Science Nation (LSN)’s early-stage ecosystem is. Attendees have had access to investor panels, workshops and could watch over 50 presenting companies in the Innovator’s Pitch Challenge. With two days down and one day left, over 1,000 meetings have already taken place through RESI’s unique, match-based partnering platform. With our next RESI, taking place during JP Morgan Healthcare Week, right around the corner, make sure not to miss out on the next opportunity to take part in a virtual event that truly works! Sign up by November 28 to save $300!

Digital RESI at JPM

11 Nov

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Digital Redefining Early Stage Investment (RESI) returns to JP Morgan in its successful virtual format January 11-13, 2022! JPM Week is the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.

Digital RESI levels the playing field by offering quality content and compelling programs, like the Innovator’s Pitch Challenge, and match-based partnering fraction of the cost of the other partnering conferences.

Registration $895 $1,795 €1,995
Registration + Pitch Fee $1,695 $5,745 €2,240

*Prices as of today

The team at Life Science Nation understands the financial, logistical, and other non-tangible barriers to entry when it comes to early-stage fundraising. This is why Digital RESI is affordable, accessible, and designed to connect partnerships that are based on product fit and stage of development. To ensure founders are set up for optimal success, we also feature several complimentary fundraising bootcamps available to the public to introduce founders to our system, as well as provide resources and proven strategies to help them get started on the right foot!

Get to know your business development representative to learn what Digital RESI has to offer you on your unique fundraising journey and sign up for Digital RESI JPM, January 11-13 by November 28 to save $300 on super early bird rates.


Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International East Coast (USA) & China Midwest (USA)
& Canada
West Coast  (USA)
Greg Mannix
Vice President International Business Development
Book a Meeting
Candice He
Vice President of Business Development, Global Investment Strategist
Book a Meeting
Antoinette Lowre
Manager of Business Development
Book a Meeting
Alexander Vassallo
Manager of Business Development
Book a Meeting

Digital RESI November Final Agenda

11 Nov

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


It’s been a busy week at Life Science Nation! As the audience chatters and orchestra buzzes in the moments before curtain opens on a show, the week before Digital RESI November 16-18 has been filled with booking meetings, partnering tutorials, panel planning calls, and putting the finishing touches on pitch materials. The energy is in the air and there’s nothing like it!

Check out some of the content coming to you virtually through Digital RESI November next week. Each session has been carefully crafted to highlight the best in early-stage life science and healthcare, and every feature is designed to connect fundraising founders with investors and strategic partners who are a fit for their product and stage of development.

  Tuesday (11/16) Wednesday (11/17) Thursday (11/18)
All Day Partnering
10AM EST Innovator’s Pitch Challenge #1 Diagnostics First Republic Bank Workshop – How to Evaluate Your Banking Partner Innovator’s Pitch Challenge #9 Longevity – Medical Devices
Innovator’s Pitch Challenge #5 Oncology Therapeutics
11AM EST Oncology Innovation Panel Cognitive Care Panel Digital Health Panel
Innovator’s Pitch Challenge #2 Medical Devices Innovator’s Pitch Challenge #10 Therapeutics
12PM EST TriNet Workshop – Piecing Together the Talent Puzzle MWE Workshop – Negotiating Term Sheets Burns & Levinson Licensing Workshop
1PM EST Innovator’s Pitch Challenge #3 R&D/Therapeutics Innovator’s Pitch Challenge #6 AI – Drug Discovery Innovator’s Pitch Challenge #11 Novel Drug Delivery
Tales from the Road: AI Innovators on their Fundraising Journey
2PM EST AI-Assisted Remote Care & Chronic Disease Management Panel Investing in Precision Medicine Panel Women in Age-Tech Panel
3PM EST MedTech Strategics Panel Clinical & Research Data Panel Impact Investors Panel
4PM EST Tales from the Road: Age-Tech Innovators on their Fundraising Journey Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey  
Innovator’s Pitch Challenge #7 Longevity – Therapeutics & Digital Health
5PM EST Angels & Family Offices Panel Innovator’s Pitch Challenge #8 Medical Devices  
Innovator’s Pitch Challenge #4 AI – Medical Devices & Digital Health

If you haven’t yet signed up for Digital RESI November, sign up now! There is still time, but meeting slots are booking up fast. If you’re already looking ahead to 2022, sign up for Digital RESI JPM early to save on super early bird rates!


Embracing the Early-Stage Journey

11 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

David Dlesk is a seasoned entrepreneur and investor, passionate about therapeutic innovation, which has led him to co-found Embrace Prevention Care, a company dedicated to safe and effective medication adherence for older adults. David has decades of experience in early-stage life science and healthcare, and has learned how to lead, connect, and accept sound advice. Listen to our recent conversation and join David at Digital RESI November, where he’ll be featured on the Tales from the Road: Age-Tech Innovators on their Fundraising Journey panel on November 16 at 4 PM EST. If you’re an early-stage fundraising executive, there’s still time to sign up and book meetings!


Hot Investor Mandate: Venture Arm of Global Services Firm Invests in Software-Based Technologies in the Healthcare Sector, Focusing on Seed to Series A Companies Globally

11 Nov

A venture fund of a global firm that provides software-based services to multiple industries, including healthcare and the life sciences does both venture investing and forms strategic partnerships with companies that are aligned with the firm’s current or future services. As an investor, the firm will generally invest between $200K-3M in seed-series A rounds. For partnerships, the firm is looking for companies looking to scale, potentially working in concert to build clients. The firm will invest and partner globally.

The firm invests in companies developing software-based technologies. Examples of the firm’s services include software for healthcare, such as hospital automation and clinical workflow, as well as virtual care and medical adherence, among others. In the life sciences space, the firm is interested in technologies such as software for connected devices, AI/ML platforms for drug discovery, as well as cell or gene therapies, or decentralized clinical trials, as examples.

The firm is only interested in companies that represent a strategic fit, either for currently offered services, or for complementary services that could expand the firm’s portfolio of services.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

%d bloggers like this: